| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |